Metabolomic imaging for human prostate cancer detection

Science Translational Medicine

Volumn 2, Issue 16, 2010, Pages

  Wu, Chin Lee ^a   Jordan, Kate W ^a   Ratai, Eva M ^a   Sheng, Jinhua ^b   Adkins, Christen B ^a   DeFeo, Elita M ^a   Jenkins, Bruce G ^a   Ying, Leslie ^b   McDougal, W Scott ^a   Cheng, Leo L ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b University of Wisconsin Milwaukee   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

TUMOR MARKER;

ARTICLE; CANCER DIAGNOSIS; CANCER RISK; CANCER STAGING; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; GLEASON SCORE; HEALTH CARE UTILIZATION; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMAGE QUALITY; MALE; METABOLIC CAPACITY; METABOLITE; METABOLOMICS; MOLECULAR DYNAMICS; NUCLEAR MAGNETIC RESONANCE IMAGING; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; PRIORITY JOURNAL; PROSTATE BIOPSY; PROSTATE CANCER; PROSTATECTOMY; TUMOR VOLUME; VOXEL BASED MORPHOMETRY; WHOLE BODY SCANNER;

DIAGNOSTIC IMAGING; HUMANS; MALE; METABOLOMICS; MIDDLE AGED; PHANTOMS, IMAGING; PRINCIPAL COMPONENT ANALYSIS; PROSTATE; PROSTATIC NEOPLASMS;

EID: 77953007681     PISSN: 19466234     EISSN: 19466242     Source Type: Journal    
DOI: 10.1126/scitranslmed.3000513     Document Type: Article

References (34)

1. G. P. Haas, N. B. Delongchamps, R. F. Jones, V. Chandan, A. M. Serio, A. J. Vickers, M. Jumbelic, G. Threatte, R. Korets, H. Lilja, G. de la Roza, Needle biopsies on autopsy prostates: Sensitivity of cancer detection based on true prevalence. J. Natl. Cancer Inst. 99, 1484-1489 (2007).
2. G. L. Andriole, E. D. Crawford, R. L. Grubb III, S. S. Buys, D. Chia, T. R. Church, M. N. Fouad, E. P. Gelmann, P. A. Kvale, D. J. Reding, J. L. Weissfeld, L. A. Yokochi, B. O'Brien, J. D. Clapp, J. M. Rathmell, T. L. Riley, R. B. Hayes, B. S. Kramer, G. Izmirlian, A. B. Miller, P. F. Pinsky, P. C. Prorok, J. K. Gohagan, C. D. Berg; PLCO Project Team, Mortality results from a randomized prostate-cancer screening trial. N. Engl. J. Med. 360, 1310-1319 (2009).
3. F. H. Schröder, J. Hugosson, M. J. Roobol, T. L. Tammela, S. Ciatto, V. Nelen, M. Kwiatkowski, M. Lujan, H. Lilja, M. Zappa, L. J. Denis, F. Recker, A. Berenguer, L. Määttänen, C. H. Bangma, G. Aus, A. Villers, X. Rebillard, T. van der Kwast, B. G. Blijenberg, S. M. Moss, H. J. de Koning, A. Auvinen; ERSPC Investigators, Screening and prostate-cancer mortality in a randomized European study. N. Engl. J. Med. 360, 1320-1328 (2009).
4. D. E. Hansel, A. M.DeMarzo, E. A. Platz, S. Jadallah, J. Hicks, J. I. Epstein, A. W. Partin, G. J.Netto, Early prostate cancer antigen expression in predicting presence of prostate cancer in men with histologically negative biopsies. J. Urol. 177, 1736-1740 (2007).
5. P. Carroll, K. Lee, Z. Fuks, P. Kantoff, in Cancer: Principle and Practice of Oncology, V. DeVita, S. Hellman, S. Rosenberg, Eds. (Lippincott Williams & Wilkins, Philadelphia, 2001).
6. D. R. Simpson, J. D. Lawson, S. K. Nath, B. S. Rose, A. J. Mundt, L. K. Mell, Utilization of advanced imaging technologies for target delineation in radiation oncology. J. Am. Coll. Radiol. 6, 876-883 (2009).
7. J. K. Kim, Y. J. Jang, G. Cho, Multidisciplinary functional MR imaging for prostate cancer. Korean J. Radiol. 10, 535-551 (2009).
8. Y. Mazaheri, H. Hricak, S. W. Fine, O. Akin, A. Shukla-Dave, N. M. Ishill, C. S. Moskowitz, J. E. Grater, V. E. Reuter, K. L. Zakian, K. A. Touijer, J. A. Koutcher, Prostate tumor volume measurement with combined T2-weighted imaging and diffusion-weighted MR: Correlation with pathologic tumor volume. Radiology 252, 449-457 (2009).
9. P. Puech, E. Potiron, L. Lemaitre, X. Leroy, G. P. Haber, S. Crouzet, K. Kamoi, A. Villers, Dynamic contrast-enhanced-magnetic resonance imaging evaluation of intraprostatic prostate cancer: Correlation with radical prostatectomy specimens. Urology 74, 1094-1099 (2009).
10. X. Z. Wang, B. Wang, Z. Q. Gao, J. G. Liu, Z. Q. Liu, Q. L. Niu, Z. K. Sun, Y. X. Yuan, 1H-MRSI of prostate cancer: The relationship between metabolite ratio and tumor proliferation. Eur. J. Radiol., 10.1016/j.ejrad.2008.10.035 (2008).
11. A. Shukla-Dave, H. Hricak, C. Moskowitz, N. Ishill, O. Akin, K. Kuroiwa, J. Spector, M. Kumar, V. E. Reuter, J. A. Koutcher, K. L. Zakian, Detection of prostate cancer with MR spectroscopic imaging: An expanded paradigm incorporating polyamines. Radiology 245, 499-506 (2007).
12. 1H MR spectroscopic imaging-correlation with pathologic findings. Radiology 246, 480-488 (2008).
13. T. W. Scheenen, S. W. Heijmink, S. A. Roell, C. A. Hulsbergen-Van de Kaa, B. C. Knipscheer, J. A. Witjes, J. O. Barentsz, A. Heerschap, Three-dimensional proton MR spectroscopy of human prostate at 3 T without endorectal coil: Feasibility. Radiology 245, 507-516 (2007).
14. N. M. deSouza, S. A. Reinsberg, E. D. Scurr, J. M. Brewster, G. S. Payne, Magnetic resonance imaging in prostate cancer: The value of apparent diffusion coefficients for identifying malignant nodules. Br. J. Radiol. 80, 90-95 (2007).
15. P. Tiwari, M. Rosen, A. Madabhushi, A hierarchical spectral clustering and nonlinear dimensionality reduction scheme for detection of prostate cancer from magnetic resonance spectroscopy (MRS). Med. Phys. 36, 3927-3939 (2009).
16. A. Sreekumar, L. M. Poisson, T. M. Rajendiran, A. P. Khan, Q. Cao, J. Yu, B. Laxman, R. Mehra, R. J. Lonigro, Y. Li, M. K. Nyati, A. Ahsan, S. Kalyana-Sundaram, B. Han, X. Cao, J. Byun, G. S. Omenn, D. Ghosh, S. Pennathur, D. C. Alexander, A. Berger, J. R. Shuster, J. T. Wei, S. Varambally, C. Beecher, A. M. Chinnaiyan, Metabolomic profiles delineate potential role for sarcosine in prostate cancer progression. Nature 457, 910-914 (2009).
17. J. L. Griffin, J. P. Shockcor, Metabolic profiles of cancer cells. Nat. Rev. Cancer 4, 551-561 (2004).
18. J. L. Spratlin, N. J. Serkova, S. G. Eckhardt, Clinical applications of metabolomics in oncology: A review. Clin. Cancer Res. 15, 431-440 (2009).
19. L. L. Cheng, M. A. Burns, J. L. Taylor, W. He, E. F. Halpern, W. S. McDougal, C. L. Wu, Metabolic characterization of human prostate cancer with tissue magnetic resonance spectroscopy. Cancer Res. 65, 3030-3034 (2005).
20. L. L. Cheng, C. L. Lean, A. Bogdanova, S. C. Wright Jr., J. L. Ackerman, T. J. Brady, L. Garrido, Enhanced resolution of proton NMR spectra of malignant lymph nodes using magic-angle spinning. Magn. Reson. Med. 36, 653-658 (1996).
21. L. L. Cheng, M. J. Ma, L. Becerra, T. Ptak, I. Tracey, A. Lackner, R. G. González, Quantitative neuropathology by high resolution magic angle spinning proton magnetic resonance spectroscopy. Proc. Natl. Acad. Sci. U.S.A. 94, 6408-6413 (1997).
22. 1H NMR spectroscopy at 9.4 T. FEBS Lett. 494, 112-116 (2001).
23. H. Hricak, P. L. Choyke, S. C. Eberhardt, S. A. Leibel, P. T. Scardino, Imaging prostate cancer: A multidisciplinary perspective. Radiology 243, 28-53 (2007).
24. L. L. Cheng, U. Pohl, in The Handbook of Metabonomics and Metabolomics, J. C. Lindon, J. K. Nicholls, E. Holmes, Eds. (Elsevier, Amsterdam, 2007), pp. 345-374.
25. C. E. Mountford, R. L. Somorjai, P. Malycha, L. Gluch, C. Lean, P. Russell, B. Barraclough, D. Gillett, U. Himmelreich, B. Dolenko, A. E. Nikulin, I. C. Smith, Diagnosis and prognosis of breast cancer by magnetic resonance spectroscopy of fine-needle aspirates analysed using a statistical classification strategy. Br. J. Surg. 88, 1234-1240 (2001).
26. B. Sitter, S. Lundgren, T. F. Bathen, J. Halgunset, H. E. Fjosne, I. S. Gribbestad, Comparison of HR MAS MR spectroscopic profiles of breast cancer tissue with clinical parameters. NMR Biomed. 19, 30-40 (2006).
27. 1H HR-MAS spectroscopy. Magn. Reson. Med. 55, 1257-1264 (2006).
28. 1H MR spectroscopy and MR imaging: Clinicopathologic case-controlled study. Radiology 221, 380-390 (2001).
29. A. P. Chen, C. H. Cunningham, E. Ozturk-Isik, D. Xu, R. E. Hurd, D. A. Kelley, J. M. Pauly, J. Kurhanewicz, S. J. Nelson, D. B. Vigneron, High-speed 3T MR . J. Magn. Reson. Imaging 25, 1288-1292 (2007).
30. A. P. Chen, C. H. Cunningham, J. Kurhanewicz, D. Xu, R. E. Hurd, J. M. Pauly, L. Carvajal, K. Karpodinis, D. B. Vigneron, High-resolution 3D MR spectroscopic imaging of the prostate at 3T with the MLEV-PRESS sequence. Magn. Reson. Imaging 24, 825-832 (2006).
31. 1H-MR spectroscopic imaging of the human prostate at 3T. Magn. Reson. Med. 53, 1268-1274 (2005).
32. C. H. Cunningham, D. B. Vigneron, M. Marjanska, A. P. Chen, D. Xu, R. E. Hurd, J. Kurhanewicz, M. Garwood, J. M. Pauly, Sequence design for magnetic resonance spectroscopic imaging of prostate cancer at 3T. Magn. Reson. Med. 53, 1033-1039 (2005). (Pubitemid 40627778)
33. D. H. Kim, D. Margolis, L. Xing, B. Daniel, D. Spielman, In vivo prostate magnetic resonance spectroscopic imaging using two-dimensional J-resolved PRESS at 3T. Magn. Reson. Med. 53, 1177-1182 (2005).
34. J. J. Fütterer, T.W. Scheenen, H. J. Huisman, D.W. Klomp, F. A. van Dorsten, C.A. Hulsbergen-van de Kaa, J. A. Witjes, A. Heerschap, J. O. Barentsz, Initial experience of 3 tesla endorectal coil magnetic resonance imaging and 1H-spectroscopic imaging of the prostate. Invest. Radiol. 39, 671-680 (2004).